Trichomegaly of the eyelashes following treatment with cetuximab.
Vaccaro
M
M
Pollicino
A
A
Barbuzza
O
O
Guarneri
B
B
D000230:Adenocarcinoma / Q000188:drug therapy; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000009:adverse effects*; D000068818:Cetuximab; D003110:Colonic Neoplasms / Q000188:drug therapy; D005140:Eyelashes / Q000187:drug effects*; D006201:Hair Diseases / Q000139:chemically induced*; D006801:Humans; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068818:Cetuximab